Work

Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)

Year: 2023

Type: article

Study design: Clinical Trial

Source: European Urology Oncology

DOI: 10.1016/j.euo.2023.09.011

Authors: Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, Jing Xie, Mark Sidhom, Abhijit Pal, Peter Grimison, Alison Zhang, Siobhan Ng, Colin Tang, Elizabeth Hovey, Colin Chen, George Hruby, Alexander Guminski, Margaret McJannett, Ciara Conduit, Ben Tran, Ian D. Davis, Dickon Hayne

Institutions: Austin Hospital, Austin Health, Peter MacCallum Cancer Centre, Victorian Comprehensive Cancer Centre, Liverpool Hospital, Chris O’Brien Lifehouse, Sir Charles Gairdner Hospital, Prince of Wales Hospital, Royal North Shore Hospital, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Eastern Health, Monash University, Fiona Stanley Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: MSD Australia, National Health and Medical Research Council

Award: More accurate disease assessment and improved clinical decision-making for patients with urothelial cancers

OpenAlex ID: W4387428673

FWCI: 4.719

Cites: 36

Cited by: 22

Related to: 10